DRKS00020290招募中不适用
RADprecise - Personalized radiotherapy: incorporating cellular response to irradiation in personalized treatment planning to minimize radiation toxicity - RADprecise
Deutsches Krebsforschungszentrum (DKFZ) / German Cancer Research Center0 个研究点目标入组 1,050 人开始时间: 2020年1月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,050
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Adult breast or prostate cancer patients who received radiotherapy and have participated in the REQUITE study in Germany, Italy, Spain, UK and who are alive at re-contact
- •- Willingness and ability to comply with at least one scheduled visit
- •- The capacity to understand the patient information sheet and the ability to provide written informed consent
排除标准
- •- Re-irradiation of the region of initial radiotherapy (including contralateral breast)
- •- Any breast surgery after initial RT, mastectomy patients (including contralateral breast)
- •- Mental disability or patient otherwise unable to give informed consent and/or complete patient questionnaires
- •- Known HIV infection, hepatitis B or hepatitis C not eligible for sample collection
研究者
相似试验
暂停
Unknown
Radiobiological characterisation and therapy monitoring of oligo- compared to polymetastatic breast cancerC50Malignant neoplasm of breastDRKS00031591Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf50
尚未招募
不适用
Towards Response guided ADAptive Radiotherapy for organ preserving treatment of intermediate risk rectal cancer: a phase I dose finding trialrectal carcinomarectal cancer100179901001799110017998NL-OMON51912niversitair Medisch Centrum Utrecht45
招募中
不适用
Towards Response guided ADAptive Radiotherapy for organ preserving treatment of intermediate risk rectal cancer: a phase I dose finding trialrectal cancerNL-OMON22916MC Utrecht45
尚未招募
Unknown
Radiationtreatment planning for Cervical and Head andNeck cancer using machineCTRI/2023/05/053119Medical Research Council University College London
进行中（未招募）
2 期
MR-Guided Adaptive Stereotactic Body Radiotherapy (SBRT) of Primary Tumor for Pain Control in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) – a Randomized, Controlled Clinical StudyC25Malignant neoplasm of pancreasDRKS00025801MU Klinikum10